Persistence of hepatitis A virus antibodies after primary immunization and response to revaccination in children and adolescents with perinatal HIV exposure

[1]  F. Matin,et al.  Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2]  C. Antoniou,et al.  Hepatitis A vaccination and immunological parameters in HIV-infected patients. , 2013, Viral immunology.

[3]  Felipe García,et al.  Factors associated with the immune response to hepatitis A vaccination in HIV-infected patients in the era of highly active antiretroviral therapy. , 2013, Vaccine.

[4]  B. McMahon,et al.  Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10‐year follow‐up , 2012, Hepatology.

[5]  M. Wallace,et al.  Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults. , 2011, The Journal of infectious diseases.

[6]  J. Wood,et al.  Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic status. , 2011, Vaccine.

[7]  R. Palacios,et al.  Impact of Acute Hepatitis A Virus (HAV) Infection on HIV Viral Load in HIV-Infected Patients and Influence of HIV Infection on Acute HAV Infection , 2011, Journal of the International Association of Physicians in AIDS Care.

[8]  W. Moss,et al.  Do children infected with HIV receiving HAART need to be revaccinated? , 2010, The Lancet. Infectious diseases.

[9]  Guo‐zhang Xu,et al.  Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children. , 2010, Vaccine.

[10]  L. Aurpibul,et al.  Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Paige L. Williams,et al.  Declines in Mortality Rates and Changes in Causes of Death in HIV-1-Infected Children During the HAART Era , 2010, Journal of acquired immune deficiency syndromes.

[12]  N. Hearst,et al.  CONTINUING IMPROVEMENT IN SURVIVAL FOR CHILDREN WITH ACQUIRED IMMUNODEFICIENCY SYNDROME IN BRAZIL , 2009, The Pediatric infectious disease journal.

[13]  Philimon N. Gona,et al.  Virologic and Immunologic Correlates With the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on Highly Active Antiretroviral Treatment , 2009, Journal of acquired immune deficiency syndromes.

[14]  P. Palma,et al.  Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children , 2009, Proceedings of the National Academy of Sciences.

[15]  W. Borkowsky,et al.  Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy. , 2008, The Journal of infectious diseases.

[16]  P. Vial,et al.  Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[17]  W. Powderly,et al.  Predictors of immunity after hepatitis A vaccination in HIV‐infected persons , 2007, Journal of viral hepatitis.

[18]  B. McMahon,et al.  Immunogenicity of an Inactivated Hepatitis A Vaccine in Infants and Young Children , 2007, The Pediatric infectious disease journal.

[19]  É. Ono,et al.  Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  D. M. Machado,et al.  Prevalência de anticorpos contra o vírus da hepatite A em crianças e adolescentes expostos e/ou infectados pelo HIV , 2005 .

[21]  R. Succi,et al.  [The prevalence of hepatitis A antibodies in HIV exposed and/or infected children and adolescents]. , 2005, Jornal de pediatria.

[22]  A. Poirier,et al.  Prolonged hepatitis A infection in an HIV‐1 seropositive patient , 2002, Journal of medical virology.

[23]  S. Antinori,et al.  Persisting HIV-1 Replication Triggered by Acute Hepatitis a Virus Infection , 2000, Antiviral therapy.

[24]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .